Fig. 2From: Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trialCourse of daily median SMS and median pollen counts during the 21-day observational periods in the birch pollen season after one (above) and two courses (below) of SCIT, respectivelyBack to article page